Olema reports Q3 2026 results, reiterates early-2027 OPERA-01 data timelineNov 16Regulatory decisionOlema Pharmaceuticals, Inc.palazestrant
Roche registers giredestrant Phase 3 trial; six other studies updateNov 6Weekly roundup, 16 itemsAbbViealectinibUpdated
Pfizer registers four studies: elranatamab, berobenatide, tilrekimig, and completed etrasimod trialOct 23Weekly roundup, 14 itemsabrocitinibatirmociclibUpdated
Genentech lists Phase Ib KRAS G12D trial; Roche-sponsored DLBCL study shows updateOct 9Weekly roundup, 9 itemsalectinibcisplatinUpdated
Roche posts HCC trial results, registers five new studies across cancer, MS, flu, COPDSep 18Weekly roundup, 6 itemsbaloxavir marboxilcevostamab